BROOKE SELLERS: Open Payments
NPI 1639305964 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 56 payments from 15 companies in 2025. Trend: 2023 $945 · 2024 $1,656 · 2025 $1,336
Food & beverage: $1,336
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $282 |
| AstraZeneca Pharmaceuticals LP | 7 | $240 |
| Philips North America LLC | 6 | $141 |
| E.R. Squibb & Sons, L.L.C. | 6 | $119 |
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| Medicure Pharma Inc. | 1 | $100 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Shockwave Medical, Inc | 1 | $37 |
Products named: ELIQUIS, FARXIGA, Ambulatory Monitoring & Diagnostics Undivided, LEQVIO, Zypitamag, VERQUVO, CAMZYOS, LifeVest.
Industry payments across AL — which companies pay providers there.
